- Home
- EVGN vs SNSE Comparison
EVGN vs SNSE Comparison
Compare EVGN & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- SNSE
- Stock Information
- Founded
- EVGN 1999
- SNSE 2005
- Country
- EVGN Israel
- SNSE United States
- Employees
- EVGN N/A
- SNSE N/A
- Industry
- EVGN Agricultural Chemicals
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- SNSE Health Care
- Exchange
- EVGN Nasdaq
- SNSE Nasdaq
- Market Cap
- EVGN 9.7M
- SNSE 9.3M
- IPO Year
- EVGN N/A
- SNSE 2021
- Fundamental
- Price
- EVGN $1.23
- SNSE $0.34
- Analyst Decision
- EVGN Strong Buy
- SNSE Strong Buy
- Analyst Count
- EVGN 1
- SNSE 4
- Target Price
- EVGN $12.00
- SNSE $4.25
- AVG Volume (30 Days)
- EVGN 1.1M
- SNSE 114.1K
- Earning Date
- EVGN 05-21-2025
- SNSE 05-06-2025
- Dividend Yield
- EVGN N/A
- SNSE N/A
- EPS Growth
- EVGN N/A
- SNSE N/A
- EPS
- EVGN N/A
- SNSE N/A
- Revenue
- EVGN $8,511,000.00
- SNSE N/A
- Revenue This Year
- EVGN $68.62
- SNSE N/A
- Revenue Next Year
- EVGN $66.92
- SNSE N/A
- P/E Ratio
- EVGN N/A
- SNSE N/A
- Revenue Growth
- EVGN 50.90
- SNSE N/A
- 52 Week Low
- EVGN $0.95
- SNSE $0.25
- 52 Week High
- EVGN $9.00
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- EVGN 57.21
- SNSE 40.28
- Support Level
- EVGN $1.09
- SNSE $0.33
- Resistance Level
- EVGN $1.23
- SNSE $0.38
- Average True Range (ATR)
- EVGN 0.07
- SNSE 0.03
- MACD
- EVGN 0.02
- SNSE -0.01
- Stochastic Oscillator
- EVGN 92.99
- SNSE 8.06
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).